India’s first global CAR T-cell therapy for Non-Hodgkin’s Lymphoma launched
India’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL), a kind of blood cancer that affects ...
Kiran Mazumdar Shaw-backed Immuneel rolls out CAR-T cancer therapy in India today, will ...
The therapy can cost anywhere between $350,000 and $700,000 globally. While Immuneel has brought it down to about ₹51 lakh to ...